EVOFEM BIOSCIENCES, INC. 01-18-2018

Company

Invesco Ltd.

Filed

January 18, 2018

Accession Number

0000914208-18-000012

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →